Transforming growth factor β receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells

Molecular Brain Research

Volumn 121, Issue 1-2, 2004, Pages 146-150

  Chattopadhyay, Naibedya ^a   Hansen, Jacob T Felt ^a   Godbole, Madan M ^b   Brown, Edward M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Activin A; Angiogenesis; BMP; Proliferation; Tumor

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR; BONE MORPHOGENETIC PROTEIN 2; LIGAND; MESSENGER RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; ASTROCYTOMA; ASTROCYTOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 1242328762     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2003.11.008     Document Type: Article

References (41)

1. Abounader R., Ranganathan S., Lal B., Fielding K., Book A., Dietz H., Burger P., Laterra J. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J. Natl. Cancer Inst. 91:1999;1548-1556.
2. Abounader R., Ranganathan S., Kim B.Y., Nichols C., Laterra J. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma. J. Neurochem. 76:2001;1497-1508.
3. Blanquaert F., Pereira R.C., Canalis E. Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts. Am. J. Physiol., Endocrinol Metabol. Gastrointest. Physiol. 278:2002;E509-E515.
4. Cameron V.A., Nishimura E., Mathews L.S., Lewis K.A., Sawchenko P.E., Vale W.W. Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. Endocrinology. 134:1994;799-808.
5. Cao B., Su Y., Oskarsson M., Zhao P., Kort E.J., Fisher R.J., Wang L.M., Vande Woude G.F. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor display antitumor activity in animal models. Proc. Natl. Acad. Sci. U. S. A. 98:2001;7443-7448.
6. Chattopadhyay N., Butters R.R. Jr., Brown E.M. Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. Mol. Brain Res. 87:2001;100-108.
7. Chattopadhyay N., Tfelt-Hansen J., Brown E.M. PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells. Mol. Brain Res. 102:2002;73-82.
8. 3 inhibits hepatocyte growth factor (HGF) synthesis and secretion from MG-63 human osteosarcoma cells. Am. J. Physiol., Endocrinol Metabol. Gastrointest. Physiol. 284:2003;E219-E227.
9. D'Alessandro J.S., Wang W.A. Bone morphogenetic proteins inhibit proliferation, induce reversible differentiation and prevent cell death in astrocyte lineage cells. Growth Factors. 11:1994;45-52.
10. D'Alessandro J.S., Yetz-Aldape J., Wang E.A. Bone morphogenetic proteins induce differentiation in astrocyte lineage cells. Growth Factors. 11:1994;53-69.
11. Dennler S., Goumans M.J., ten Dijke P. Transforming growth factor β signal transduction. J. Leukoc. Biol. 71:2002;731-740.
12. Di Renzo M.F., Bertolotto A., Olivero M., Putzolu P., Crepaldi T., Schiffer D., Pagni C.A., Comoglio P.M. Selective expression of the Met/HGF receptor in human central nervous system microglia. Oncogene. 8:1993;219-222.
13. Fakhrai H., Dorigo O., Shawler D.L., Lin H., Mercola D., Black K.L., Royston I., Sobol R.E. Eradication of established intracranial rat gliomas by transforming growth factor β antisense gene therapy. Proc. Natl. Acad. Sci. U. S. A. 93:1996;2909-2914.
14. Hamanoue M., Takemoto N., Matsumoto K., Nakamura T., Nakajima K., Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J. Neurosci. Res. 43:1996;554-564.
15. Hao H.N., Zhao J., Thomas R.L., Parker G.C., Lyman W.D. Fetal human hematopoietic stem cells can differentiate sequentially into neural stem cells and then astrocytes in vitro. J. Hematother. Stem Cell Res. 12:2003;23-32.
16. Isoe S., Naganuma H., Nakano S., Sasaki A., Satoh E., Nagasaka M., Maeda S., Nukui H. Resistance to growth inhibition by transforming growth factor (in malignant glioma cells with functional receptors. J. Neurosurg. 88:1998;529-534.
17. Jachimczak P., Schwulera U., Bogdahn U. In vitro studies of cytokine-mediated interactions between malignant glioma and autologous peripheral blood mononuclear cells. J. Neurosurg. 81:1994;579-586.
18. Jiang J.G., Johnson C., Zarnegar R. Peroxisome proliferator-activated receptor γ-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element. J. Biol. Chem. 276:2001;25049-25056.
19. Kilpatrick T.J., Ortuno D., Bucci T., Lai C., Lemke G. Rat oligodendroglia express c-met and focal adhesion kinase, protein tyrosine kinases implicated in regulating epithelial cell motility. Neurosci. Lett. 279:2000;5-8.
20. Kjellman C., Olofsson S.P., Hansson O., Von Schantz T., Lindvall M., Nilsson I., Salford L.G., Sjogren H.O., Widegren B. Expression of TGFβ isoforms, TGFβ receptors, and SMAD molecules at different stages of human glioma. Int. J. Cancer. 89:2000;251-258.
21. Laterra J., Rosen E., Nam M., Ranganathan S., Fielding K., Johnston P. Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. Biochem. Biophys. Res. Commun. 235:1997;743-747.
22. Lamszus K., Schmidt N.O., Jin L., Laterra J., Zagzag D., Way D., Witte M., Weinand M., Goldberg I.D., Westphal M., Rosen E.M. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int. J. Cancer. 75:1998;19-28.
23. Moriyama T., Kataoka H., Koono M., Wakisaka S. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors. Int. J. Mol. Med. 3:1999;531-536.
24. Nakano N., Morishita R., Moriguchi A., Nakamura Y., Hayashi S.I., Aoki M., Kida I., Matsumoto K., Nakamura T., Higaki J., Ogihara T. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor β in blood vessels: potential role of HGF in cardiovascular disease. Hypertension. 32:1998;444-451.
25. Ohga E., Matsuse T., Teramoto S., Ouchi Y. Activin receptors are expressed on human lung fibroblast and activin A facilitates fibroblast-mediated collagen gel contraction. Life Sci. 66:2000;1603-1613.
26. Piek E., Westermark U., Kastemar M., Heldin C.H., van Zoelen E.J., Nister M., Ten Dijke P. Expression of transforming-growth-factor (TGF)-β receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-β1. Int. J. Cancer. 80:1999;756-763.
27. Pollard J.W. Tumour-stromal interactions. Transforming growth factor-β isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res. 3:2001;230-237.
28. Platten M., Wick W., Weller M. Malignant glioma biology: role for TGF-β in growth, motility, angiogenesis, and immune escape. Microsc. Res. Tech. 52:2001;401-410.
29. Rich J.N., Zhang M., Datto M.B., Bigner D.D., Wang X.F. Transforming growth factor-β-mediated p15(INK4B) induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. J. Biol. Chem. 274:1999;35053-35058.
30. Satoh M., Sugino H., Yoshida T. Activin promotes astrocytic differentiation of a multipotent neural stem cell line and an astrocyte progenitor cell line from murine central nervous system. Neurosci. Lett. 284:2000;143-146.
31. Schluesener H.J. Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type beta 1, beta 2, and beta 1.2. J. Neurosci. Res. 28:1991;310-314.
32. Schluesener H.J., Meyermann R. Spontaneous multidrug transport in human glioma cells is regulated by transforming growth factors type beta. Acta Neuropathol. (Berl.). 81:1991;641-648.
33. Stander M., Naumann U., Dumitrescu L., Heneka M., Loschmann P., Gulbins E., Dichgans J., Weller M. Decorin gene transfer-mediated suppression of TGF-β synthesis abrogates experimental malignant glioma growth in vivo. Gene Ther. 5:1998;1187-1194.
34. Stolz D.B., Michalopoulos G.K. Differential modulation of hepatocyte growth factor-stimulated motility by transforming growth factor β1 on rat liver epithelial cells in vitro. J. Cell. Physiol. 175:1998;30-40.
35. Ten Dijke P., Goumans M.J., Itoh F., Itoh S. Regulation of cell proliferation by Smad proteins. J. Cell. Physiol. 191:2002;1-16.
36. Tfelt-Hansen J., Schwarz P., Terwilliger E.F., Brown E.M., Chattopadhyay N. Calcium-sensing receptor induces mRNA of human securin, pituitary tumor transforming gene, in rat testicular cancer. Endocrinology. 144:2003;5188-5193.
37. Welch W.C., Kornblith P.L., Michalopoulos G.K., Petersen B.E., Beedle A., Gollin S.M., Goldfarb R.H. Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells. Anticancer Res. 19:1999;1635-1640.
38. Wick W., Grimmel C., Wild-Bode C., Platten M., Arpin M., Weller M. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-β2. J. Neurosci. 21:2001;3360-3368.
39. Wordinger R.J., Agarwal R., Talati M., Fuller J., Lambert W., Clark A.F. Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol. Vis. 8:2002;241-250.
40. Yamada T., Tsubouchi H., Daikuhara Y., Prat M., Comoglio P.M., McGeer P.L., McGeer E.G. Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues. Brain Res. 637:1994;308-312.
41. Yamanaka R., Tanaka R., Yoshida S., Saitoh T., Fujita K., Naganuma H. Suppression of TGF-β1 in human gliomas by retroviral gene transfection enhances susceptibility to LAK cells. J. Neuro-Oncol. 43:1999;27-34.